Case Reports in Immunology / 2018 / Article / Fig 5

Case Report

Effective Immunotherapy in Bone Marrow Metastatic Melanoma Presenting with Disseminated Intravascular Coagulopathy

Figure 5

FDA-approved immunohistochemical stain for PD-L1, clone 28-8, (OPDIVO®) positive in 10.0% tumor cells with weak intensity.

We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.